Siguru targets commercial launch after fundraise

A Sheffield-founded technology business has secured fresh investment to develop its artificial intelligence platform and support its next stage of growth.

Siguru Ltd, founded by entrepreneurs Dan Bentley and Harry Bliss in May 2025, has completed its second external seed fundraising round.

The business is developing an AI-powered system for medical, legal and regulatory affairs review within the pharmaceutical sector.

Dan and Harry say the latest funding will support further development of the technology, help validate market demand and prepare Siguru for growth across UK and international pharmaceutical companies.

Investment is being raised through selected angel investors, friends, family and industry contacts.

Siguru has also assembled a team of medical and commercial specialists with more than 250 years of combined MLR experience, working alongside AI experts to develop the platform.

Harry said: “We are an ambitious, high tech company at the forefront of AI technology-based systems. 

“Our products can be used by marketing and commercial teams, medical affairs and governance, digital teams, and leadership – anywhere approval speed and compliance both matter. 

“The thriving online market offers high opportunities for growth.

“Our AI platform supports pharma marketing and medical teams through the MLR process – aiming to reduce approval timelines from 40 days to a week.

“Further development of the products and business through the funding will move us towards a commercial launch with the hiring of employees and improvements on a minimum viable product.

“Siguru will expand through developing partnerships and go-to-market, working closely with medical and compliance leaders to build for real-world pharma workflows.”

Tom Haywood and Aaron Patel, from Sheffield law firm Wake Smith Solicitors’ company and commercial team, advised Siguru on the fundraising.

The firm also handled the legal work for Siguru's first external funding round, continuing its support as the technology business moves through its early stages of development and prepares to scale.

Tom added: “These two rounds of funding confirm a healthy appetite for investment into the right companies at all levels and supports the North’s burgeoning AI market.

“People invest in companies, but, just as importantly, founders and this investment is an endorsement of their work in the creation of market-leading, innovative products. 

“The investors bring together variety of interests and skills – from tech, business, medicine and pharma to work on a really exciting product and we look forward to seeing how it develops.”

Want your business, product or service to be seen regionally and nationally? Bdaily helps you get your story in front of the right audience, every day. Find out how Bdaily can help →

Join more than 55,000 subscribers by signing up to our daily bulletin each morning here.